Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$18,204,644
+$2,492,297 QoQ
Shares Held
72,344
+0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#653
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $100,006,894 across 14 Drug Manufacturers - General names. ABBV ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,430 | $35,299,227 | |
| 2 | JNJ |
Johnson & Johnson
|
89,578 | $22,750,124 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
72,344 | $18,204,644 | |
| 4 | MRK |
Merck & Co., Inc.
|
136,408 | $17,528,428 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
37,785 | $2,177,171 | |
| 6 | NVS |
Novartis AG
|
7,847 | $1,229,781 | |
| 7 | PFE |
Pfizer Inc
|
50,191 | $1,208,599 | |
| 8 | AMGN |
Amgen Inc
|
2,744 | $993,657 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,204,644 | 72,344 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $15,712,347 | 72,244 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $17,134,465 | 74,990 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $17,590,788 | 75,973 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,065,541 | 75,776 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $16,215,590 | 77,394 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $12,810,748 | 72,092 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $14,620,431 | 74,035 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $12,223,372 | 71,265 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $13,002,122 | 71,401 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $10,493,173 | 67,711 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $10,124,751 | 67,924 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,159,619 | 67,985 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,824,091 | 67,918 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $11,083,698 | 68,583 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $9,141,848 | 68,116 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $10,006,861 | 65,336 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $10,948,098 | 67,535 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $9,129,345 | 67,425 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $7,448,531 | 69,051 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $7,856,752 | 69,751 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $7,548,453 | 69,751 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,670,118 | 71,583 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,734,166 | 65,466 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,303,548 | 64,204 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,868,312 | 63,897 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||